InsiderTrades

Form 4 for INTA Intapp, Inc.

Accepted 2026-08-07 16:06:46 ET · period of report 2026-08-05 · accession 0001565687-26-000067 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2026-08-07 16:06 2026-08-05 INTA HALL JOHN T CEO, Dir M - OptEx $7.45 +75.0K 5.96M +1% +$558.8K
DT 2026-08-07 16:06 2026-08-05 INTA HALL JOHN T CEO, Dir S - Sale+OE $36.86 -146.7K 5.81M -2% -$5.41M
DT 2026-08-07 16:06 2026-08-05 INTA HALL JOHN T CEO, Dir M - OptEx $0.00 -75.0K 88.0K -46% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-05 M A 75,000 $7.45 5,961,482 D — — (F1) The option exercise and sale of shares of common stock of Intapp, Inc. was executed pursuant to a 10b5-1 plan put in place by the Reporting Person on December 15, 2025.
2 Common Common Stock 2026-08-05 S D 146,674 $36.86 5,814,808 D — — (F1) The option exercise and sale of shares of common stock of Intapp, Inc. was executed pursuant to a 10b5-1 plan put in place by the Reporting Person on December 15, 2025. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.50 to $37.38, inclusive. The reporting person undertakes to provide to Intapp, Inc., any security holder of Intapp, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
3 Derivative Employee Stock Option (Right to Buy) 2026-08-05 M D 75,000 $0.00 88,000 D $7.45 · — to 2027-07-26 75,000 Common Stock (F1) The option exercise and sale of shares of common stock of Intapp, Inc. was executed pursuant to a 10b5-1 plan put in place by the Reporting Person on December 15, 2025. (F3) The shares underlying this option are fully vested and exercisable as of the date hereof.